product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
Goat anti Mouse IgG2b
catalog :
STAR134
quantity :
0.5 mg
price :
156 USD
clonality :
polyclonal
host :
domestic goat
conjugate :
nonconjugated
application :
ELISA
more info or order :
citations: 1
| Reference |
|---|
Relic B, Charlier E, Deroyer C, Malaise O, Crine Y, Neuville S, et al. Serum starvation raises turnover of phosphorylated p62/SQSTM1 (Serine 349), reveals expression of proteasome and N-glycanase1 interactive protein RAD23B and sensitizes human synovial fibroblasts to BAY 11-7085-induced cell death. Oncotarget. 2018;9:35830-35843 pubmed publisher
|
image
image 1 :
Figure A. Purified mouse anti bovine CD1w3 ( MCA1647G ) detected with goat anti mouse IgG2b RPE ( STAR134PE ) and FITC conjugated mouse IgG1 isotype control ( MCA928F ). Figure B. Purified mouse anti bovine CD1w3 ( MCA1647G ) detected with goat anti mouse IgG2b RPE ( STAR134PE ) and FITC conjugated mouse anti bovine CD40 ( MCA2431F ). All experiments performed on red cell lysed bovine blood gated on mononuclear cells.
product information
Entity Type :
Polyclonal Antibody
Entity Category :
Antibodies
ProductCode :
STAR134
Description :
Goat anti Mouse IgG2b
Specificity :
IgG2b
TargetSpecies :
Mouse
Host :
Goat
Format :
Purified
Isotypes :
Polyclonal IgG
Applications :
E
ApplicationTypes :
ELISA
Cross Reactivities :
Human
Quantity :
0.5 mg
Quantity Value :
0.5
Quantity Type :
mg
GO Accessions :
GO:0005886,GO:0003823,GO:0016021,GO:0005576
GOTerms :
plasma membrane,antigen binding,integral to membrane,extracellular region
Uniprot Accessions :
P01867
Gene :
Ighg2b
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=16016
Entity Formats :
Alk. Phos.,FITC,HRP,Purified,RPE
UNSPSC :
41116161
Concentration :
IgG concentration 1.0mg/ml
Product Form :
Purified IgG - liquid
PriceGBP :
130
PriceEUR :
156
PriceUSD :
156 USD
PriceCHF :
170
PriceSEK :
1700
PriceNOK :
1709
PriceDKK :
1163
NotForSaleInCountries :
KR
more info or order :
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.